Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 09/03/2012
PIL CUBICIN 350 mg powder for concentrate for solution for injection or infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 17/02/2011 and displayed until 09/03/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to MA holder contact details
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to Further Information section
Updated on 24/09/2010 and displayed until 17/02/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 06/08/2009 and displayed until 24/09/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change of trade or generic name
Updated on 19/02/2008 and displayed until 06/08/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 14/09/2007 and displayed until 19/02/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 03/01/2007 and displayed until 14/09/2007
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 06/02/2006 and displayed until 03/01/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  daptomycin